NEBIVOL H 5/12.5MG TAB

Nebivol H 5/12.5mg combines nebivolol, a selective beta-1 blocker, with hydrochlorothiazide, a thiazide diuretic, to provide dual-action cardiovascular support. This combination formulation is designed to help manage hypertension by reducing heart rate and cardiac workload while promoting sodium and fluid excretion. The synergistic approach addresses multiple pathways in blood pressure regulation, making it suitable for patients requiring enhanced antihypertensive efficacy. Each tablet delivers precise dosing for consistent therapeutic outcomes. Consult your healthcare provider to determine if this medication aligns with your treatment plan.